NCIC-CTG MA14 Trial: Tamoxifen (tam) vs. tam plus octreotide (oct) for adjuvant treatment of stage I or II postmenopausal breast cancer Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Pollak, MN
  • Chapman, JW
  • Pritchard, KI
  • Krook, JE
  • Dhaliwal, HS
  • Vandenberg, TA
  • Norris, BD
  • Whelan, Timothy
  • Wilson, CF
  • Shepherd, LE

publication date

  • May 20, 2008